These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. Kasper S; Hajak G; Wulff K; Hoogendijk WJ; Montejo AL; Smeraldi E; Rybakowski JK; Quera-Salva MA; Wirz-Justice AM; Picarel-Blanchot F; Baylé FJ J Clin Psychiatry; 2010 Feb; 71(2):109-20. PubMed ID: 20193645 [TBL] [Abstract][Full Text] [Related]
23. The effects of sertraline on psychopathic traits. Dunlop BW; DeFife JA; Marx L; Garlow SJ; Nemeroff CB; Lilienfeld SO Int Clin Psychopharmacol; 2011 Nov; 26(6):329-37. PubMed ID: 21909028 [TBL] [Abstract][Full Text] [Related]
24. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression. Lydiard RB; Stahl SM; Hertzman M; Harrison WM J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414 [TBL] [Abstract][Full Text] [Related]
25. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. Brunoni AR; Valiengo L; Baccaro A; Zanão TA; de Oliveira JF; Goulart A; Boggio PS; Lotufo PA; Benseñor IM; Fregni F JAMA Psychiatry; 2013 Apr; 70(4):383-91. PubMed ID: 23389323 [TBL] [Abstract][Full Text] [Related]
26. The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder. Durham LK; Webb SM; Milos PM; Clary CM; Seymour AB Psychopharmacology (Berl); 2004 Aug; 174(4):525-9. PubMed ID: 12955294 [TBL] [Abstract][Full Text] [Related]
27. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial. Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916 [TBL] [Abstract][Full Text] [Related]
28. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Glassman AH; Bigger JT; Gaffney M Arch Gen Psychiatry; 2009 Sep; 66(9):1022-9. PubMed ID: 19736359 [TBL] [Abstract][Full Text] [Related]
29. Plasma serotonin levels are associated with antidepressant response to SSRIs. Holck A; Wolkowitz OM; Mellon SH; Reus VI; Nelson JC; Westrin Å; Lindqvist D J Affect Disord; 2019 May; 250():65-70. PubMed ID: 30831543 [TBL] [Abstract][Full Text] [Related]
30. A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder. Lépine JP; Caillard V; Bisserbe JC; Troy S; Hotton JM; Boyer P Am J Psychiatry; 2004 May; 161(5):836-42. PubMed ID: 15121648 [TBL] [Abstract][Full Text] [Related]
31. Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, on Perceived Stress and Cognitive Function Among Patients With Late-Life Depression: A Randomized, Double-Blind, Sertraline- and Placebo-Controlled Trial. Lin CH; Wang SH; Lane HY Int J Neuropsychopharmacol; 2022 Aug; 25(7):545-555. PubMed ID: 35023557 [TBL] [Abstract][Full Text] [Related]
32. Sertraline: a review of its use in the management of major depressive disorder in elderly patients. Muijsers RB; Plosker GL; Noble S Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324 [TBL] [Abstract][Full Text] [Related]
33. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Lyketsos CG; DelCampo L; Steinberg M; Miles Q; Steele CD; Munro C; Baker AS; Sheppard JM; Frangakis C; Brandt J; Rabins PV Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778 [TBL] [Abstract][Full Text] [Related]
34. [Use of antidepressant drugs in schizophrenic patients with depression]. Micallef J; Fakra E; Blin O Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628 [TBL] [Abstract][Full Text] [Related]
35. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Croft H; Settle E; Houser T; Batey SR; Donahue RM; Ascher JA Clin Ther; 1999 Apr; 21(4):643-58. PubMed ID: 10363731 [TBL] [Abstract][Full Text] [Related]
36. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients. Sechter D; Troy S; Paternetti S; Boyer P Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324 [TBL] [Abstract][Full Text] [Related]
37. Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study. Lyketsos CG; Sheppard JM; Steele CD; Kopunek S; Steinberg M; Baker AS; Brandt J; Rabins PV Am J Psychiatry; 2000 Oct; 157(10):1686-9. PubMed ID: 11007727 [TBL] [Abstract][Full Text] [Related]
38. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Thase ME; Fava M; Halbreich U; Kocsis JH; Koran L; Davidson J; Rosenbaum J; Harrison W Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754 [TBL] [Abstract][Full Text] [Related]
39. A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia. Mulholland C; Lynch G; King DJ; Cooper SJ J Psychopharmacol; 2003 Mar; 17(1):107-12. PubMed ID: 12680747 [TBL] [Abstract][Full Text] [Related]